MICROPHARM LIMITED

Active Newcastle Emlyn

Manufacture of basic pharmaceutical products

79 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
M

MICROPHARM LIMITED

Manufacture of basic pharmaceutical products

Founded 18 Aug 1998 Active Newcastle Emlyn, United Kingdom 79 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
Accounts Submitted 3 Oct 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 27 Aug 2025 Next due 1 Sept 2026 3 months remaining
Net assets £1M £2M 2024 year on year
Total assets £17M £3M 2024 year on year
Total Liabilities £16M £5M 2024 year on year
Charges 5
1 outstanding 4 satisfied

Contact & Details

Contact

Registered Address

Units F & G Station Road Industrial Estate Station Road Newcastle Emlyn Carmarthenshire SA38 9BY United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for MICROPHARM LIMITED (03617656), an active life sciences and medical technology company based in Newcastle Emlyn, United Kingdom. Incorporated 18 Aug 1998. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Apr → 31 Mar 2025
Type medium
Next accounts 31 Mar 2026
Due by 31 Dec 2026 7 months remaining

Balance Sheet & P&L (2013–2024)

Cash in Bank

£450.99k

Increased by £420.30k (+1369%)

Net Assets

£1.08M

Decreased by £2.46M (-69%)

Total Liabilities

£16.04M

Increased by £5.06M (+46%)

Turnover

£4.88M

Increased by £2.26M (+86%)

Employees

79

Increased by 13 (+20%)

Debt Ratio

94%

Increased by 18 (+24%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Mar Year End
2023
31 Mar Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 535,000 Shares £1360.06m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
2 Jul 201575,000£30k£0.4
13 Aug 201350,000£5k£0.1
18 Jul 2013250,000£25k£0.1
14 Dec 200960,000£360.00m£6k
4 Dec 2009100,000£1000.00m£10k

Officers

Officers

1 active 2 resigned
Status
David Edward WaltersDirectorBritishUnited Kingdom7529 Sept 2014Active

Shareholders

Shareholders (17)

Flynn Pharma (holdings) Limited
75.8%
John Landon
11.2%

Persons with Significant Control

Persons with Significant Control (1)

1 Active
Active
Notified 6 Apr 2016
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Group Structure

Group Structure

MICROPHARM LIMITED Current Company

Charges

Charges

1 outstanding 4 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
27 Mar 2026CapitalAllotment of shares (GBP 7,188,730.5) on 25 Mar 2026
12 Feb 2026OfficersTermination of John Landon as director on 31 Dec 2025
3 Oct 2025AccountsAnnual accounts made up to 31 Mar 2025
27 Aug 2025Confirmation StatementConfirmation statement made on 18 Aug 2025 with no updates
24 Dec 2024AccountsAnnual accounts made up to 31 Mar 2024
27 Mar 2026 Capital

Allotment of shares (GBP 7,188,730.5) on 25 Mar 2026

12 Feb 2026 Officers

Termination of John Landon as director on 31 Dec 2025

3 Oct 2025 Accounts

Annual accounts made up to 31 Mar 2025

27 Aug 2025 Confirmation Statement

Confirmation statement made on 18 Aug 2025 with no updates

24 Dec 2024 Accounts

Annual accounts made up to 31 Mar 2024

Recent Activity

Latest Activity

Allotment of shares (GBP 7,188,730.5) on 25 Mar 2026

1 months ago on 27 Mar 2026

Termination of John Landon as director on 31 Dec 2025

3 months ago on 12 Feb 2026

Annual accounts made up to 31 Mar 2025

7 months ago on 3 Oct 2025

Confirmation statement made on 18 Aug 2025 with no updates

9 months ago on 27 Aug 2025

Annual accounts made up to 31 Mar 2024

1 years ago on 24 Dec 2024